首页> 美国卫生研究院文献>Asian Pacific Journal of Cancer Prevention : APJCP >Effects of Genistein and Synergistic Action in Combination with Tamoxifen on the HepG2 Human Hepatocellular Carcinoma Cell Line
【2h】

Effects of Genistein and Synergistic Action in Combination with Tamoxifen on the HepG2 Human Hepatocellular Carcinoma Cell Line

机译:金雀异黄素及其协同作用与他莫昔芬联用对人肝癌细胞HepG2的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction:The flavonoids comprise a diverse group of polyphenolic compounds with antioxidant activity that is present in edible plants like soybeans and soy products. In vivo studies have concentrated on the effects of flavonoids on cancer and genistein (GE), a soy-derived isoflavone, has been reported to reduce prostate, colon, hepatic and breast adenocarcinoma risk. Tamoxifen (TAM) is an important drug for cancer treatment worldwide, which can induce apoptosis in various cancers, including examples in the liver, breast and ovaries. The aim of the present study was to evaluate the effects of GE and TAM, alone and in combination, on proliferation and apoptosis in the human hepatocellular carcinoma (HCC) HepG2 cell line.
机译:简介:类黄酮包含多种具有抗氧化活性的多酚化合物,存在于大豆和大豆制品等食用植物中。体内研究集中在黄酮类化合物对癌症的影响上,据报道大豆异黄酮(染料木黄酮)可降低前列腺癌,结肠癌,肝癌和乳腺腺癌的风险。他莫昔芬(TAM)是全世界治疗癌症的重要药物,它可以诱导各种癌症的凋亡,包括肝癌,乳腺癌和卵巢癌。本研究的目的是评估GE和TAM单独或组合对人肝细胞癌(HCC)HepG2细胞系增殖和凋亡的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号